Skip to main content

Regeneron Pharmaceuticals, Inc 10-K for FY2022

Regeneron Pharmaceuticals, Inc. (REGN)

10-K 2023-02-06 For: 2022-12-31
View Original
Added on April 08, 2026

About this 10-K

Regeneron Pharmaceuticals, Inc filed this 10-K on February 6, 2023, covering the fiscal year ended December 31, 2022 (FY2022).

Headline figures

Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$12.17B
down 24.3% from $16.07B a year earlier
Net income
$4.34B
down 46.3% from net income of $8.08B a year earlier
Diluted EPS
$38.22
down 46.9% from $71.97 a year earlier